Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.137 |
---|---|
High | 0.168 |
Low | 0.1253 |
Bid | 0.153 |
Offer | 0.1565 |
Previous close | 0.1322 |
Average volume | 4.08m |
---|---|
Shares outstanding | 75.49m |
Free float | 60.48m |
P/E (TTM) | -- |
Market cap | 11.70m USD |
EPS (TTM) | -0.7706 USD |
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
- The Oncology Institute Reports Third Quarter 2024 Financial Results
- The Oncology Institute Announces Certification to Administer Pluvicto Therapy in California
- The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call
- The Oncology Institute Joins Lantern’s Cancer Care Network of Excellence
- The American Journal of Managed Care® and The Oncology Institute to Co-Host Symposium for Value-Based Cancer Care
- The Oncology Institute of Hope & Innovation Launches Oregon Market
- The Oncology Institute Announces CFO Transition
- The Oncology Institute Reports Second Quarter 2024 Financial Results and Updates Full Year 2024 Guidance
- The Oncology Institute Announces Second Quarter 2024 Earnings Release Date and Conference Call
- The Oncology Institute to Participate at Upcoming Investor Conferences
More ▼